AbbVie, Inc. <ABBV.N>: Wells Fargo raises target price to $300 from $295
ABBV•Related News
Thesis Gold & Silver prices C$58.46 million share offering led by AngloGold Ashanti
AU•
Nasdaq trade halt <EYPT.O> halt news pending at 06:55 AM
EYPT•
BlackRock raises total stake in Metso to 5.58%
BLK•
Pacira BioSciences, Inc. <PCRX.O>: Truist Securities reinstates coverage with buy rating; price target $30
PCRX•
Pulse Biosciences Inc <PLSE.O>: Needham initiates coverage with Buy rating; target price $58
PLSE•